Clinical trial • Phase I • Neurology
Clinical trial in Huntington's disease
Phase I trial for Huntington's disease. 36 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Huntington's disease
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 20-01-2026
- First CTIS Authorization Date
- 11-05-2026
Trial design
Phase I trial in Germany, Poland, Denmark and others.
- Target Sample Size
- 36
Recruitment
- Planned Sample Size
- 36
- Recruitment Window Months
- 35
Geography
- Total Number Of Sites
- 12
- Total Number Of Participants
- 31
Germany
- Earliest CTIS Part Ii Submission Date
- 24-04-2026
- Latest Decision Or Authorization Date
- 12-05-2026
- Processing Time Days
- 18
- Number Of Sites
- 4
- Number Of Participants
- 12
Sites
- Site Name
- Katholisches Klinikum Bochum gGmbH
- Department Name
- Forschungszentrum für Neurodegeneration
- Principal Investigator Name
- Carsten Saft
- Principal Investigator Email
- carsten.saft@ruhr-uni-bochum.de
- Contact Person Name
- Carsten Saft
- Contact Person Email
- carsten.saft@ruhr-uni-bochum.de
- Site Name
- Charite Universitaetsmedizin Berlin KöR
- Department Name
- Klinik für Psychiatrie und Psychotherapie
- Principal Investigator Name
- Josef Priller
- Principal Investigator Email
- josef.priller@charite.de
- Contact Person Name
- Josef Priller
- Contact Person Email
- josef.priller@charite.de
- Site Name
- Universitaetsklinikum Erlangen AöR
- Department Name
- Molekular-Neurologische Abteilung
- Principal Investigator Name
- Martin Regensburger
- Principal Investigator Email
- martin.regensburger@uk-erlangen.de
- Contact Person Name
- Martin Regensburger
- Contact Person Email
- martin.regensburger@uk-erlangen.de
- Site Name
- Universitaetsklinikum Ulm AöR
- Department Name
- Klinik für Neurologie
- Principal Investigator Name
- Bernhard Landwehrmeyer
- Principal Investigator Email
- bernhard.landwehrmeyer@uni-ulm.de
- Contact Person Name
- Bernhard Landwehrmeyer
- Contact Person Email
- bernhard.landwehrmeyer@uni-ulm.de
Poland
- Earliest CTIS Part Ii Submission Date
- 27-04-2026
- Latest Decision Or Authorization Date
- 15-05-2026
- Processing Time Days
- 18
- Number Of Sites
- 3
- Number Of Participants
- 6
Sites
- Site Name
- Mtz Clinical Research Powered By Pratia
- Department Name
- MTZ Clinical Research Powered by Pratia
- Principal Investigator Name
- Zygmunt Jamrozik
- Principal Investigator Email
- badacz@pratia.com
- Contact Person Name
- Zygmunt Jamrozik
- Contact Person Email
- badacz@pratia.com
- Site Name
- Wojskowy Instytut Medycyny Lotniczej
- Department Name
- Wojskowy Instytut Medycyny Lotniczej
- Principal Investigator Name
- Grzegorz Witkowski
- Principal Investigator Email
- 9greg@wp.pl
- Contact Person Name
- Grzegorz Witkowski
- Contact Person Email
- 9greg@wp.pl
- Site Name
- Copernicus Podmiot Leczniczy Sp. z o.o.
- Department Name
- Szpital Św. Wojciecha, Kliniczny Oddział Neurologiczny/ Udarowy GUmed
- Principal Investigator Name
- Jarosław Sławek
- Principal Investigator Email
- jaroslaw.slawek@gumed.edu.pl
- Contact Person Name
- Jarosław Sławek
- Contact Person Email
- jaroslaw.slawek@gumed.edu.pl
Denmark
- Earliest CTIS Part Ii Submission Date
- 07-05-2026
- Latest Decision Or Authorization Date
- 11-05-2026
- Processing Time Days
- 4
- Number Of Sites
- 1
- Number Of Participants
- 3
Sites
- Site Name
- Rigshospitalet
- Department Name
- Clinical Research
- Principal Investigator Name
- Lena Hjermind
- Principal Investigator Email
- lena.elisabeth.hjermind.01@regionh.dk
- Contact Person Name
- Lena Hjermind
- Contact Person Email
- lena.elisabeth.hjermind.01@regionh.dk
Italy
- Earliest CTIS Part Ii Submission Date
- 17-04-2026
- Latest Decision Or Authorization Date
- 11-05-2026
- Processing Time Days
- 24
- Number Of Sites
- 2
- Number Of Participants
- 4
Sites
- Site Name
- IRCCS Foundation Istituto Neurologico Carlo Besta
- Department Name
- Unità di Fase I
- Principal Investigator Name
- Caterina Mariotti
- Principal Investigator Email
- caterina.mariotti@istituto-besta.it
- Contact Person Name
- Caterina Mariotti
- Contact Person Email
- caterina.mariotti@istituto-besta.it
- Site Name
- Azienda Ospedaliero Universitaria Careggi
- Department Name
- Clinical Trial Unit 1
- Principal Investigator Name
- Camilla Ferrari
- Principal Investigator Email
- camilla.ferrari@unifi.it
- Contact Person Name
- Camilla Ferrari
- Contact Person Email
- camilla.ferrari@unifi.it
Portugal
- Earliest CTIS Part Ii Submission Date
- 22-04-2026
- Latest Decision Or Authorization Date
- 12-05-2026
- Processing Time Days
- 20
- Number Of Sites
- 2
- Number Of Participants
- 6
Sites
- Site Name
- CCAB Centro Clinico Academico Braga Associacao
- Department Name
- Neurology
- Principal Investigator Name
- Sara Varanda
- Principal Investigator Email
- svaranda@gmail.com
- Contact Person Name
- Sara Varanda
- Contact Person Email
- svaranda@gmail.com
- Site Name
- Unidade Local De Saude De Santa Maria E.P.E.
- Department Name
- Neurology
- Principal Investigator Name
- Leonor Guedes
- Principal Investigator Email
- lcorreiaguedes@gmail.com
- Contact Person Name
- Leonor Guedes
- Contact Person Email
- lcorreiaguedes@gmail.com
Sponsor
Primary sponsor
- Full Name
- F. Hoffmann-La Roche AG
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Switzerland
Related trials
Other published trials that may interest you.